Insider buying last 90 days
No open-market insider purchases were filed for MKL in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
Markel's week centers on a major reinsurance transaction, with Markel Insurance and Enstar finalizing a $4.8 billion adverse development cover agreement that transfers $2.3 billion in reserves from Markel's global reinsurance business to Enstar, alongside an additional $1.2 billion in adverse loss development coverage. AM Best separately commented on the credit ratings of Cavello Bay Reinsurance Limited following Enstar's transaction with Markel Group. Coverage also included a head-to-head comparison between Markel Group and Fidelity National Financial as large-cap finance companies.
Markel closed at $1951.26, up 0.6%, with its price sitting between the 50-day average of $1812.69 and the 200-day average of $1892.54. The stock's one-month return stands at 10.8%, while the three-month and six-month returns are 6% and 6.1% respectively; the one-year return is -2.9%. The GekkoIndex reads 46.5, placing the stock in the Neutral zone, with a five-day change of -3.4. Price sits 4.2% above Gekko Fair Value of $1872.75.
Markel's next earnings report is scheduled for 3 February 2027, 80 days away, placing it outside a typical 20-trading-day holding window. The prior quarter saw EPS of $19.51 against an estimate of $29.94, with a reaction of -7.5%; the company has beaten estimates in 5 of the last 8 quarters. Seasonality from this point has averaged a 2.8% gain over the next 20 trading days across 5 years, rising in 4 of them. One billionaire holder is recorded, while insider, Congressional and options activity show no data in their respective windows.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Markel scores 2 supportive, 3 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive3 mixed0 headwinds
Averages disagree
Close $1977.29 sits between the 50-day ($1825.25) and 200-day ($1891.59) averages, or the averages disagree.
See the chart47.5, Neutral
Reading 47.5 is in the Neutral zone.
See the GekkoIndex4.8% above
Price is within 5% of Gekko Fair Value (4.8% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 80 days
Next report Feb 3, 2027, 80 days away — outside a typical 20-trading-day hold.
See earnings+1.9% on average
From this point in the calendar, the next 20 trading days averaged +1.9% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Markel closed at $1,977.29 on Nov 13, 2026, −5.5% over the past year, inside a 52-week range of $1,704.17 to $2,207.59.
Use the left and right arrow keys to read daily values.
Put MKL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Markel underwrites specialty insurance and reinsurance policies for clients located in North America, Bermuda, Britain, parts of Europe, Canada, Asia Pacific markets, and the Middle East. Its insurance offerings include liability protection, personal coverage, marine and energy policies, workers' compensation, and custom specialty programs, as well as property insurance that guards against fire damage and severe weather events like quakes and windstorms, plus credit, surety, and collateral-related products. On the reinsurance front, Markel handles risk tied to transactions, healthcare claims, and environmental liabilities, alongside treaty-based programs covering credit, political risk, mortgages, and commercial surety.
Apart from underwriting, Markel runs a separate group of companies under its Ventures arm that make things like food-processing and baking machinery, dredging equipment, vehicle transporters, wood flooring, plants, homes, handbags, and building trim, while other units within that arm offer services such as distributing exterior products, renting cranes, fire safety work, business consulting, and retail data analysis. A further part of the company deals in healthcare, leasing, and investment activity, where it manages funds and insurance-related assets, offering tools like catastrophe bonds, weather-linked derivatives, and swap contracts tied to insurance risk, sometimes managing these funds jointly with outside firms.
Markel trades on the NYSE under the ticker MKL.
Markel’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 47.5, in the Neutral zone, up 0.9 points over five sessions.
Up 0.9 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 38 | +1.0% | +4.1% | ||
| Accumulation | 193 | +1.0% | +2.5% | ||
| Neutral (current zone) | 433 | −0.1% | 0.0% | ||
| Distribution | 37 | −0.6% | −1.4% | ||
| Selling | 1 | Too few readings yet | |||
Average MKL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Markel trades 4.8% above Gekko Fair Value of $1,887.22, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Markel shares are worth, recalculated every trading day.
$1,887.22
Gekko Fair Value, Nov 14, 2026
4.8% above fair value · About fair value
At the end of Aug 2026 the price was 6.9% below the estimate.
No open-market insider purchases were filed for Markel, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for MKL in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in MKL were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Markel has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds MKL.
Markel reports on Feb 3, 2027 (80 days away), and beat the EPS estimate in 5 of its last 8 reports.
Feb 3, 2027
80 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 29, 2026 | $19.51 est $29.94 | $5.19B est $4.50B | −7.5% |
| Apr 28, 2026 | $23.55 est $26.34 | $2.82B est $3.66B | −7.2% |
| Feb 4, 2026 | $34.45 est $27.62 | $4.22B est $3.64B | +2.8% |
| Oct 29, 2025 | $30.90 est $24.02 | $4.39B est $3.75B | +5.5% |
| Jul 30, 2025 | $25.46 est $24.97 | $4.41B est $4.82B | −0.5% |
| Apr 30, 2025 | $25.72 est $16.77 | $3.33B est $3.92B | +0.3% |
| Feb 5, 2025 | $20.51 est $19.00 | $4.02B est $3.16B | +12.1% |
| Oct 30, 2024 | $17.34 est $21.43 | $4.50B est $3.96B | −1.4% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Markel is $1,980.17, +0.1% from the last close.
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Markel averaged +1.9% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.8% | 2 of 5 |
| Next 10 trading days | +1.3% | 4 of 5 |
| Next 15 trading days | +1.8% | 4 of 5 |
| Next 20 trading days | +1.9% | 4 of 5 |
| Next 30 trading days | +2.6% | 4 of 5 |
For scale, MKL’s typical 20-trading-day move in either direction is about 3.6%.
Markel’s market cap is $24.18B, with a P/E ratio of 14 and revenue of $16.11B over the last twelve months.
Coverage of Markel this week reads neutral: 0 positive, 3 neutral and 1 negative headlines.
Markel’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| BRK.ABerkshire Hathaway | Distribution | 10.8% above |
| BRK.BBerkshire Hathaway | Distribution | 9.8% above |
| CBChubb | Neutral | 4.8% above |
| TRVTravelers Companies | Neutral | 6.3% above |
| HIGHartford Insurance | Neutral | 0.1% below |
| LLoews | Neutral | 25.3% above |
A peer links to its own page where one exists.
Markel’s market cap is $24.18B at the Nov 13, 2026 close of $1,977.29, with 12.23M shares outstanding. The shares trade on a P/E ratio of 14.
The consensus analyst 12-month price target for Markel is $1,980.17, +0.1% from the last close. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Markel is about fair value: the Nov 13, 2026 close of $1,977.29 is 4.8% above Gekko Fair Value of $1,887.22. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Markel is expected to report on Feb 3, 2027 (80 days away). Analysts expect earnings of $28.78 per share on revenue of $3.82B. Markel beat the earnings estimate in 5 of its last 8 reports, moving 4.7% on average across the report.
Markel’s 52-week high is $2,207.59 and its 52-week low is $1,704.17; it closed at $1,977.29 on Nov 13, 2026, −5.5% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (earnings risk and seasonality), 3 as mixed (trend, gekkoindex and fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.